p21WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivo

Journal of Cancer Research and Clinical Oncology

Volumn 129, Issue 8, 2003, Pages 463-471

  Kralj, Marijeta ^a   Pavelić, Jasminka ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Apoptosis; Gene therapy; P21WAF1 CIP1; P53; Renca cells

Indexed keywords

ADENOVIRUS VECTOR; DNA FRAGMENT; LIPOCORTIN 5; PROTEIN P21; PROTEIN P53; ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; ENZYME INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CARCINOMA CELL; CELL LINE; CELL STRAIN RENCA; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ADENOVIRUS; ANIMAL; APOPTOSIS; CELL CULTURE; DRUG EFFECT; GENE VECTOR; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY CARCINOMA; KIDNEY TUMOR; PATHOLOGY; TIME; UPREGULATION;

ADENOVIRIDAE; ANIMALS; ANNEXIN A5; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MICE; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0042354183     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-003-0458-2     Document Type: Article

References (39)

1. (WAF1/CIP1) retards the growth of human squamous cell carcinomas in vivo. Oral Oncol 34:211-218
2. Clayman GL, Liu TJ, Overholt SM, Mobley SR, Wang M, Janot F, Goepfert H (1996) Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21). Arch Otolaryngol Head Neck Surg 122:489-493
3. D'Orazi G, Marchetti A, Crescenzi M, Coen S, Sacchi A, Soddu S (2000) Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting. J Gene Med 2:11-21
4. WAF1/CIP1: more than a break to the cell cycle. Biochim Biophys Acta 1471:M43-M56
5. CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis. J Cell Biochem 64:434-446
6. Eastham JA, Hall SJ, Sehgal I, Wang J, Timme TL, Yang, G Connell-Crowley L, Elledge SJ, Zhang WW, Harper JW, Thompson TC (1995) In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res 55:5151-5155
7. Ekholm SV, Reed SI (2000) Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 12:676-684
8. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825
9. Evan GI, Vousden KH (2001) Proliferation, cell cycle, and apoptosis in cancer. Nature 411:342-348
10. WAF1/CIP1 transgene on radiation induced apoptosis in T cells. Oncogene 18:3652-3658
11. Gallagher WM, Brown R (1999) p53-oriented cancer therapies: current progress. Ann Oncol 10:139-150
12. Gartel AL, Serfas MS, Tyner AL (1996) p21-negative regulator of the cell cycle. Proc Soc Exp Biol Med 213:138-149
13. CDKN4) in human prostate cancers. J Urol 158:636-641
14. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816
15. Herrmann M, Lorenz HM, Voll R, Grunke M, Woith W, Kalden JR (1994) A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acid Res 22:5506-5507
16. cip-1/WAF-1, which promotes apoptosis. J Immunol 164:4032-4036
17. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R, Harris CC (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acid Res 24:141-146
18. WAF1 recombinant adenovirus. Pancreas 16:107-113
19. Katayose D, Wersto R, Cowan KH, Seth P (1995) Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle and apoptosis. Cell Growth Differ 6:1207-1212
20. WAF1/CIP1 overexpression. Cancer Gene Ther 10:457-467
21. Li Z, Rakkar A, Katayose Y, Kim M, Shanmugam N, Srivastava S, Moul JW, McLeod DG, Cowan KH, Seth P (1998) Efficacy of multiple administrations of recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model. Gene Ther 5:605-613
22. Nielsen LL, Maneval DC (1998) p53 tumor suppressor gene therapy for cancer. Cancer Gene Ther 5:52-63
23. Nielsen LL, Dell J, Maxwell E, Armstrong L, Maneval D, Catino JJ (1997) Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Cancer Gene Ther 4:129-138
24. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90-98
25. Parker LP, Wolf JK, Price JE (2000) Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines. Ann Clin Lab Sci 30:395-405
26. Ramondetta L, Mills GB, Burke TW, Wolf JK (2000) Adenovirus-mediated expression of p53 or p21 in papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Clin Cancer Res 6:278-284
27. Waf1/Cip1/Sdi1: association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179:1-14
28. Roth JA, Cristiano RJ (1997) Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 89:21-39
29. Sekiguchi T, Hunter T (1998) Induction of growth arrest and cell death by overexpression of the cyclin-Ckd inhibitor p21 in hamster BHK21 cells Oncogene 16:369-380
30. Sheikh MS, Rochefort H, Garcia M (1995) Overexpression of p21 WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 11:1899-1905
31. Sherr CJ (1996) Cancer cell cycles. Science 274:1672-1677
32. Shibata M-A, Yoshidome K, Shibata E, Jorcyk CL, Green JE (2001) Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21. Cancer Gene Ther 8:23-25
33. Stewart ZA, Pietenpol JA (2001) p53 signaling and cell cycle checkpoints. Chem Res Toxicol 14:243-263
34. Waf1/Cip1 gene transfer induces apoptosis of human cervical cancer cell lines. J Virol 73:4983-4990
35. Vousden KH (2000) p53: Death star. Cell 103:691-694
36. Wallace-Brodeur RR, Lowe SW (1999) Clinical implications of p53 mutations. Cell Mol Life Sci 55:64-75
37. Yang ZY, Perkins ND, Ohno T, Nabel EG, Nabel GJ (1995) The p21 cyclin-dependent kinase inhibitor suppress tumorigenicity in vivo. Nature Med. 1:1052-1056
38. Zhang WW (1999) Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther 6:113-138
39. Zhang WW, Fang XM, Mazur W, French BA, Georges RN, Roth JA (1994) High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1:5-13